238 results on '"Deluche, Elise"'
Search Results
2. Management of patients with advanced epithelial ovarian cancer: a European survey
3. Administration des anti-HER2 et satisfaction des patients avec un cancer du sein
4. ACACIAS 3 : Apprentissage des consultations d’annonce dans le deuxième cycle d’études médicales
5. ACACIAS 1 : impacts physiologiques et subjectifs de la simulation haute-fidélité lors de l’annonce de mauvaises nouvelles
6. Prognosis and chemosensitivity of non-colorectal alimentary tract cancers with microsatellite instability
7. Application en France des recommandations européennes 2021 sur le cancer de l’endomètre
8. Surgical management of patients with advanced ovarian cancer: Results of a French National Survey
9. Relationship between the creatinine/cystatin C ratio and muscle mass measured by CT-scan in cancer patients
10. The prevalence of CT-defined low skeletal muscle mass in patients with metastatic cancer: a cross-sectional multicenter French study (the SCAN study)
11. Basics of immunotherapy for epithelial ovarian cancer
12. Is sarcopenia a missed factor in the management of patients with metastatic breast cancer?
13. Multicenter evaluation of breast cancer patients’ satisfaction and experience with oncology telemedicine visits during the COVID-19 pandemic
14. Place des inhibiteurs de kinases dépendantes des cyclines 4/6 dans la prise en charge du cancer du sein avancé
15. Comparison of 18FDG-PET/CT and conventional follow-up methods in colorectal cancer: A randomised prospective study
16. Impact of body mass index on overall survival in patients with metastatic breast cancer
17. Surgical Site Infections after glioblastoma surgery: results of a multicentric retrospective study
18. Contemporary outcomes of metastatic breast cancer among 22,000 women from the multicentre ESME cohort 2008–2016
19. Simulation haute-fidélité à la consultation d’annonce en oncologie médicale
20. Treatment and outcomes in patients with central nervous system metastases from breast cancer in the real-life ESME MBC cohort
21. Variability of treatment of locally advanced cervical cancer: How French multidisciplinary teams follow European guidelines?
22. THERANOVA-LIM: Optimizing the city hospital link to support patients on oral anticancer drugs
23. Le Collège national des enseignants de cancérologie (CNEC) : missions, organisation et projets
24. Clinical utility of circulating tumour cell-based monitoring of late-line chemotherapy for metastatic breast cancer: the randomised CirCe01 trial
25. Degradation of skeletal mass in locally advanced oesophageal cancer between initial diagnosis and recurrence
26. Characteristics and outcome of breast cancer-related microangiopathic haemolytic anaemia: a multicentre study
27. Chimiothérapie et femme jeune dans le cancer du sein : quelle prise en charge ?
28. First validation of the G-8 geriatric screening tool in older patients with glioblastoma
29. Assessment of the nutritional status of adult patients with acute myeloid leukemia during induction chemotherapy
30. Bilan pour la nutrition artificielle à domicile d’une année de consultations externes de l’unité transversale de nutrition du CHU de Limoges
31. Prospective evaluation of an anti-cancer drugs management programme in a dedicated oral therapy center (DICTO programme)
32. « HER2-faible », un nouveau concept dans la prise en charge des cancers du sein: HER2-low breast cancer: a new concept in breast cancer treatment strategy
33. Physician compliance with multidisciplinary tumor board recommendations for managing gynecological cancers
34. Psoas muscle index is not representative of skeletal muscle index for evaluating cancer sarcopenia
35. Clinical management of molecular alterations identified by high throughput sequencing in patients with advanced solid tumors in treatment failure: Real-world data from a French hospital
36. 2022 : nouvelles pratiques thérapeutiques en oncologie mammaire
37. Patient Identification and Tumor Identification Management: Quality Program in a Cancer Multicentric Clinical Data Warehouse
38. Impact of body composition on outcome in patients with early breast cancer
39. Real-life efficacy and predictors of response to immunotherapy in pituitary tumors: a cohort study
40. 2022-RA-787-ESGO ESGO guidelines on the management of endometrial cancer. Weaknesses and controversies in france and french-speaking switzerland. Results of a delphi survey
41. Mechanism of action and resistance to Trastuzumab Deruxtecan in patients with metastatic breast cancer: the DAISY trial
42. Low skeletal muscle mass is clinically underestimated in advanced metastatic prostate cancer: the cross-sectional SCAN study
43. KLRC3, a Natural Killer receptor gene, is a key factor involved in glioblastoma tumourigenesis and aggressiveness
44. TEDOVA/GINECO-OV244b/ENGOT-ov58 trial: Neo-epitope based vaccine OSE2101 alone or in combination with pembrolizumab versus best supportive care (BSC) as maintenance in platinum-sensitive recurrent ovarian cancer with disease control after platinum.
45. Renin-Angiotensin-System Inhibitors for the Prevention of Chemotherapy-Induced Peripheral Neuropathy: OncoToxSRA, a Preliminary Cohort Study
46. ONCOACH, a prospective study to evaluate the impact of coaching in improving the well- being of oncologists
47. Abstract PD8-02: Trastuzumab deruxtecan (T-DXd) for advanced breast cancer patients (ABC), regardless HER2 status: A phase II study with biomarkers analysis (DAISY)
48. Primary Renal Tumour Response in Patients Treated with Nivolumab for Metastatic Renal Cell Carcinoma: Results from the GETUG-AFU 26 NIVOREN Trial
49. The prevalence of CT-defined low skeletal muscle mass in patients with metastatic cancer: a cross-sectional multicenter French study (the SCAN study)
50. Can the Six-Minute Walk Test Be Used to Individualize Physical Activity Intensity in Patients with Breast Cancer?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.